^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    CXCR5 Modified EGFR Targeted CAR-T Cells

    i
    Associations
    News

    Trials

    Company:
    Hedy Group
    Drug class:
    EGFR-targeted CAR-T immunotherapy
    Related drugs:
    Associations
    News

    Trials

    Apply
    Study of CXCR5 Modified EGFE Chimeric Antigen Receptor Autologous T Cells in EGFR- Positive Patients With Advanced Non-small Cell Lung Cancer (NCT04153799)
    Phase 1
    Sun Yat-sen University
    Recruiting
    Last update posted :
    05/12/2020
    Initiation :
    11/01/2019
    Primary completion :
    12/01/2021
    Completion :
    12/01/2022
    EGFR • CXCL13
    |
    EGFR expression
    |
    CXCR5 Modified EGFR Targeted CAR-T Cells